Northwest & Ethical Investments L.P. grew its stake in shares of Genpact Limited (NYSE:G - Free Report) by 10.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 290,166 shares of the business services provider's stock after acquiring an additional 28,068 shares during the period. Northwest & Ethical Investments L.P. owned about 0.16% of Genpact worth $11,377,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of G. CWM LLC grew its holdings in Genpact by 160.8% during the 2nd quarter. CWM LLC now owns 952 shares of the business services provider's stock valued at $31,000 after buying an additional 587 shares during the last quarter. Versant Capital Management Inc lifted its position in shares of Genpact by 4,717.8% in the second quarter. Versant Capital Management Inc now owns 2,168 shares of the business services provider's stock valued at $70,000 after acquiring an additional 2,123 shares in the last quarter. Massmutual Trust Co. FSB ADV boosted its stake in shares of Genpact by 54.3% during the second quarter. Massmutual Trust Co. FSB ADV now owns 2,797 shares of the business services provider's stock valued at $90,000 after acquiring an additional 984 shares during the last quarter. Venturi Wealth Management LLC increased its position in Genpact by 74.6% during the 3rd quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock worth $103,000 after purchasing an additional 1,121 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in Genpact by 221.3% in the 3rd quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider's stock valued at $131,000 after purchasing an additional 2,293 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on G. Jefferies Financial Group raised their price objective on Genpact from $35.00 to $40.00 and gave the stock a "hold" rating in a report on Monday, September 9th. BMO Capital Markets raised their price target on Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a research note on Monday, August 12th. JPMorgan Chase & Co. increased their price objective on shares of Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a report on Friday, September 6th. Robert W. Baird boosted their target price on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a report on Friday, November 8th. Finally, TD Cowen increased their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a "hold" rating in a research note on Friday, November 8th. Eight analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, Genpact currently has a consensus rating of "Hold" and a consensus target price of $42.33.
Read Our Latest Research Report on G
Genpact Stock Down 0.6 %
Shares of NYSE G traded down $0.28 during midday trading on Friday, reaching $46.21. 750,201 shares of the company's stock were exchanged, compared to its average volume of 1,345,405. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85. Genpact Limited has a 52-week low of $30.23 and a 52-week high of $47.98. The business's fifty day moving average price is $41.02 and its two-hundred day moving average price is $36.89. The stock has a market capitalization of $8.15 billion, a PE ratio of 12.70, a price-to-earnings-growth ratio of 1.60 and a beta of 1.13.
Genpact Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be paid a $0.1525 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.32%. Genpact's dividend payout ratio (DPR) is presently 16.76%.
Insider Transactions at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the business's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at $12,407,545.60. The trade was a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.80% of the company's stock.
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.